Is Tigan (trimethobenzamide) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Tigan (Trimethobenzamide) During Pregnancy

Tigan (trimethobenzamide) should be avoided during pregnancy if possible, as there is insufficient safety data to recommend its use, and safer alternatives with better established safety profiles are available.

Safety Classification and Evidence

  • Trimethobenzamide (Tigan) is not specifically mentioned in current pregnancy guidelines, indicating a lack of robust safety data for its use during pregnancy 1
  • For antiemetic use in pregnancy, guidelines mention other medications such as ondansetron, lorazepam, and dexamethasone as part of antiemetic regimens that have been studied in pregnant populations 1
  • The limited data on trimethobenzamide contrasts with other antihistamines that have more established safety profiles in pregnancy 1

Recommended Alternatives

  • For nausea and vomiting in pregnancy, non-pharmacological approaches should be tried first:

    • Eating small, frequent meals with higher carbohydrate and lower fat content 2
    • Avoiding bothersome food odors 2
  • If medication is necessary, consider these alternatives with better established safety profiles:

    • Pyridoxine (vitamin B6) has demonstrated safety and efficacy for pregnancy-related nausea 2
    • Loratadine or cetirizine are preferred antihistamines during pregnancy as they have been most studied 1
    • Doxylamine or promethazine may be considered as alternatives with more safety data than trimethobenzamide 2

Clinical Considerations

  • Drug safety has the highest priority in treating pregnant women, as effects on fetal development may have lifelong consequences 3
  • The American Academy of Allergy, Asthma, and Immunology suggests selecting medications with better established safety profiles during pregnancy 4
  • When considering any medication during pregnancy, the risk-benefit assessment should prioritize both maternal and fetal health 2

Important Caveats

  • Unplanned exposures to medications with limited safety data do not necessarily require immediate discontinuation, but should prompt consultation with a healthcare provider 3
  • If severe nausea and vomiting of pregnancy requires pharmacological intervention, the benefits of treatment may outweigh theoretical risks in some cases 2
  • Documentation of medication use during pregnancy is important for ongoing pharmacovigilance and safety assessment 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of nausea and vomiting in pregnancy.

American family physician, 1993

Research

The Use of Medication in Pregnancy.

Deutsches Arzteblatt international, 2019

Guideline

Hydroxyzine Use in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.